Edition:
United States

CSPC Pharmaceutical Group Ltd (1093.HK)

1093.HK on Hong Kong Stock

10.04HKD
10:25pm EDT
Change (% chg)

HK$0.00 (+0.00%)
Prev Close
HK$10.04
Open
HK$10.18
Day's High
HK$10.18
Day's Low
HK$10.00
Volume
11,512,660
Avg. Vol
15,641,813
52-wk High
HK$10.44
52-wk Low
HK$6.30

Latest Key Developments (Source: Significant Developments)

CSPC Pharmaceutical posts FY profit attributable to shareholders HK$2.10 billion
Monday, 20 Mar 2017 12:27am EDT 

Cspc Pharmaceutical Group Ltd <1093.HK> : Fy profit attributable to shareholders hk$2.10 billion versus hk$1.67 billion . Fy revenue hk$ 12.37 billion versus hk$11.39 billion .Subsequent to the end of the reporting period, a final dividend in respect of the year ended 31 dec 2016 of hk12 cents.  Full Article

CSPC Pharma announces acquisition of stake in Hebei Shiwei Pharma
Friday, 3 Mar 2017 05:19am EST 

CSPC Pharmaceutical Group Ltd <1093.HK>: Acquisition of the entire equity interest in Hebei Shiwei Pharmaceutical Trading Co . Deal for RMB200 million .Entered into agreement with CCPCL in relation to sale and purchase of entire equity interest in Hebei Shiwei.  Full Article

CSPC Pharmaceutical Group updates on order issued by Shijiazhuang City Air and Water Pollution Prevention Command office
Monday, 21 Nov 2016 06:07am EST 

CSPC Pharmaceutical Group Ltd <1093.HK> : Application has been made for resumption of trading in shares in company with effect from 9:00 a.m. On 22 november 2016 . Units in shijiazhuang city, hebei province have received (shijiazhuang city air pollution prevention scheduling order) . Making application to shijiazhuang municipal government for permission to continue normal pharmaceutical production in shijiazhuang . Sales of group's products can be fulfilled in short term out of inventories . Order requires all pharmaceutical enterprises in shijiazhuang city to suspend production .Order states shijiazhuang municipal government has decided to implement strict regulatory/controlling.  Full Article

CSPC Pharmaceutical says HY revenue of hk$6.15 bln vs hk$5.73 bln<1093.HK>
Tuesday, 23 Aug 2016 12:08am EDT 

CSPC Pharmaceutical Group Ltd <1093.HK>: 2016 interim results announcement <1093.HK> . HY profit attributable to shareholders hk$1.03 billion versus hk$822 million . HY revenue of hk$6.15 billion versus hk$5.73 billion . Directors do not declare the payment of an interim dividend for the six months ended 30 June 2016 . Directors do not declare the payment of an interim dividend .  Full Article

CSPC Pharmaceutical Group announces entery into lease agreements<1093.HK>
Monday, 27 Jun 2016 05:28am EDT 

CSPC Pharmaceutical Group Ltd <1093.HK>: Continuing connected transactions - lease agreements <1093.HK> . Says CSPC Zhongnuo (as tenant) and CHL (as landlord) entered into two new lease agreements . Lease agreements in respect of premises 1, 2 and 3 for a term of three years commenced on 25 June 2016 . Says the board confirms rental payable, being RMB18.4 million per annum in aggregate .  Full Article

CSPC Pharmaceutical says unit CSPC Shengxue Glucose Co enters into Steam Supply Agreement<1093.HK>
Monday, 13 Jun 2016 05:52am EDT 

CSPC Pharmaceutical Group Ltd <1093.HK>: 1) completion of the acquisition of 93.18% equity interest in CSPC shengxue glucose co., ltd. and (2) continuing connected transactions <1093.HK> . Says unit entered into the steam supply agreement with Hebei hongyuan . Agreement in relation to the purchase of steam by shengxue from Hebei hongyuan commencing from 13 June 2016 to 12 June 2019 .  Full Article

CSPC Pharmaceutical reports qtrly net profit of HK$505.6 mln vs HK$400.3 mln<1093.HK>
Wednesday, 18 May 2016 12:06am EDT 

CSPC Pharmaceutical Group Ltd <1093.HK>: Unaudited results for the three months ended 31 March 2016 . Qtrly revenue HK$2.99 billion versus HK$2.78 billion . Qtrly net profit HK$505.6 million versus HK$400.3 million a year ago . Board of directors does not declare payment of an interim dividend for three months ended 31 March 2016 .  Full Article

CSPC Pharmaceutical Group Ltd says benzonatate soft capsule granted drug registration approval by U.S. FDA
Wednesday, 5 Aug 2015 05:56am EDT 

CSPC Pharmaceutical Group Ltd:Says that the Group’s product “Benzonatate Soft Capsule” has passed the Abbreviated New Drug Application and was granted drug registration approval by the U.S. Food and Drug Administration.Benzonatate soft capsule is a non-narcotic cough suppressant used for relieving cough symptoms.  Full Article

More From Around the Web